New pneumonia vaccine shows promise in early safety trial
NCT ID NCT05815264
First seen Jan 08, 2026 · Last updated May 25, 2026 · Updated 20 times
Summary
This study tested a new 23-valent pneumococcal polysaccharide vaccine in 144 healthy volunteers aged 2 years and older. Participants received one dose of either the experimental vaccine or a control vaccine. The main goal was to check safety and measure the immune response. The trial is complete, and results will help decide if further testing is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Qi County Center for Disease Control and Prevention
Hebi, Henan, China
Conditions
Explore the condition pages connected to this study.